| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702591 | Urologic Oncology: Seminars and Original Investigations | 2017 | 6 Pages |
Abstract
Patients with T1b ccRCC treated with PRFA have less favorable outcomes than those with PN whereas PRFA provides comparable oncologic outcomes to PN in patients with T1b nccRCC. It is necessary to take RCC subtypes into consideration when choosing a surgical approach to treat T1b RCC between PFRA and PN.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ning M.D., Daoguang M.D., Xiangming M.D., Yankun M.D., Wei Ph.D., Weidong Ph.D, Hongqian Ph.D,